Get all your news in one place.

100's of premium titles.
One app.

Get all your news in one place.

100's of premium titles. One news app.

DARK SECRETS: 20 | Rare Historical Photos

2 Cheap Dividend Stocks to Buy This March and Hold for the Long Term

While the S&P 500 Index's dividend yield is just about half of its long-term averages, Ford and Pfizer are two dividend-paying stocks that offer healthy yields. Plus, their cheap valuations mean that there is a reasonable probability of upside over the next couple of years.

Barchart

50 Top Companies By Market Capitalization: The Global Giants

These companies are the ones that dominate the market and will continue to do so should factors remain constant.

International Business Times

Surge in syphilis cases drives some doctors to ration penicillin

The drug is the go-to treatment for syphilis and the only one recommended for pregnant people. But a shortage of the injectable drug has prompted some public health agencies to ration it.

WEKU

From analysis to the latest developments in health,
read the most diverse news in one place.

A Better Way To Fight Future Pandemics

Four years after the emergence of Covid-19, the conversation in global public health has moved on from dealing with an immediate crisis to how we can best prepare for the next pandemic.

International Business Times

Large COVID-19 vaccine study finds risks

Any pharmaceutical has risk of side effects, but a COVID infection is far more dangerous than the vaccines

Salon

Two very rare Covid vaccine side-effects detected in global study of 99 million

Results confirm how uncommon known complications are as researchers confirm benefits from vaccines still ‘vastly outweigh the risks’

The Guardian - AU

Pfizer (PFE) vs. Johnson & Johnson (JNJ) - Analyzing Pharma Stocks for Upside Potential

The pharmaceutical industry is expected to witness robust growth over the coming years due to growing healthcare needs and advancements in technology. Given this positive backdrop, let’s analyze the upside potential of pharma stocks Pfizer (PFE) and Johnson & Johnson (JNJ).

StockNews.com

Read news from The Economist, FT, and more,
with one subscription

Pfizer Stock 2025 Forecast: Will PFE Go Up Long Term?

Pfizer stock is trading at price levels last seen in 2016. The 2025 forecast for PFE stock looks positive, though, and it should go up over the medium to long term.

Barchart

Pfizer Settles M Lipitor Antitrust Lawsuit

Read about Pfizer's settlement in the Lipitor antitrust lawsuit, where they have agreed to pay million to resolve the case. Stay informed with our late...

Top News

Breaking Through: My Life in Science by Katalin Karikó review – real-life lessons in chemistry

This vivid account of the Hungarian biochemist who endured decades of derision before pioneering Pfizer’s Covid vaccine is a tribute to her tenacity and self-belief

The Guardian - UK

Pfizer (PFE): Pre-Earnings Strategies

Pfizer (PFE) is facing hurdles due to weakened demand for its products and pipeline diversification challenges. Nevertheless, the company exhibits long-term potential through strategic acquisitions. Given this scenario, what course of action should be considered ahead of the upcoming earnings release? Read more to find out.

StockNews.com

More Than 150 Infants, Pregnant Women Given Incorrect RSV Vaccine, CDC Says

According to reports, there have been 25 cases of accidental administration of Pfizer (Abrsyvo) or GSK (Arexvy) RSV vaccines to children below two and 128 cases of mistaken administration of the GSK RSV vaccine (Arexvy) to pregnant women.

Medical Daily

2024 Will Be a Good Year for the Pharma Industry: The Kiplinger Letter

Five pharma companies will have sales that exceed $50 billion this year.

Kiplinger

‘Medicine is going personalised’: Moderna’s UK boss on the coming vaccine revolution

Darius Hughes was a key figure in Pfizer’s pioneering Covid vaccine drive. Now he has changed companies – and sees a big future for mRNA technology

The Guardian - UK

Get all your
news in one place.

100's of premium titles.
One news app.

AVNetwork

CES 2024: How Tony Stark Can Save Pro AV (and Other Trends)

Artificial intelligence, electrification, hydrogen power, sustainability, human security, and mobility dominated the show floor.

The Independent UK

DEI opponents are using a 1866 Civil Rights law to challenge equity policies in the workplace

Opponents of diversity programs are increasingly banking on an 1866 civil rights law meant to protect Black people from economic exclusion as a way to challenge corporate diversity and equity policies as well as funding to Black-owned businesses

The Independent UK

As legal challenges mount, some companies retool diversity and inclusion programs

Conservative advocates have filed a growing number of legal challenges, encouraged by the Supreme Court’s June ruling ending affirmative action in college admissions

Fortune

FDA allows imports of French syphilis drug alternate during US penicillin shortage

While as little as one injection of penicillin G benzathine can cure syphilis, the shortage prompted U.S. health officials to recommend giving some patients another antibiotic that requires of weeks of twice-daily pills.

Get all your
news in one place.

100's of premium titles.
One news app.

The Canberra Times

It comes as the ACT plans to stop recording COVID numbers.

Inverse

A Biochemist Reveals The One Tech That Could Revolutionize Drug Discovery

How mRNA-based drugs interact with the immune system and how they are degraded in human cells can help lead to safe, durable, and effective treatments.

Top News

Florida Surgeon General's Claims on COVID Vaccines Debunked as Nonsense

Explore the debunked claims made by the Florida State Surgeon General regarding COVID vaccines and the integration of contaminants into DNA in this insight...

The Guardian - US

‘Scientific nonsense’: experts dismiss Florida official’s Covid vaccine remarks

State’s politically appointed surgeon general claims vaccines can contaminate human DNA but experts say comment has no merit

The Conversation

Drugs of the future will be easier and faster to make, thanks to mRNA – after researchers work out a few remaining kinks

Vaccines have been reliably and affordably protecting people from diseases worldwide for centuries. Until the COVID-19 pandemic, however, vaccine development was still a long and idiosyncratic process. Traditionally, researchers had to tailor manufacturing processes and facilities for each vaccine candidate, and the scientific knowledge gained from one vaccine was often…

1 … 19 20 21 22

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.